(19)
(11) EP 4 168 552 A1

(12)

(43) Date of publication:
26.04.2023 Bulletin 2023/17

(21) Application number: 21826483.6

(22) Date of filing: 18.06.2021
(51) International Patent Classification (IPC): 
C12N 15/50(2006.01)
A61K 39/215(2006.01)
C07K 14/165(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/14; C07K 14/005; C12N 2770/20034; C12N 2770/20022; A61K 39/12; A61K 2039/55505; A61K 2039/55561
(86) International application number:
PCT/CN2021/100826
(87) International publication number:
WO 2021/254473 (23.12.2021 Gazette 2021/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.06.2020 US 202063040696 P
01.03.2021 WO PCT/US2021/020277

(71) Applicants:
  • Medigen Vaccine Biologics Corporation
    Zhubei City, Taiwan 302 (TW)
  • Dynavax Technologies Corporation
    Emeryville, CA 94608 (US)

(72) Inventors:
  • KUO, Tsun-Yung
    Lan County, Taiwan 26341 (TW)
  • CHEN, Charles
    Taipei City, Taiwan 11493 (TW)
  • WU, Chung-Chin
    Lan County, Taiwan 26846 (TW)
  • LIN, Yi-Jiun
    Taipei City, Taiwan 11493 (TW)
  • LIN, Meei-Yun
    Taipei City, Taiwan 11493 (TW)
  • WU, Yu-Chi
    Taipei City, Taiwan 11493 (TW)
  • CAMPBELL, John, D.
    Emeryville, California 94608 (US)
  • JANSSEN, Robert, S.
    Emeryville, California 94608 (US)
  • NOVACK, David
    Emeryville, California 94608 (US)
  • COFFMANN, Robert
    Emeryville, CA 94608 (US)
  • TRAQUINA, Paula
    Emeryville, CA 94608 (US)

(74) Representative: Wittmann, Günther 
Patentanwaltskanzlei Wittmann Frans-Hals-Straße 31
81479 München
81479 München (DE)

   


(54) IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)